SPOTLIGHT -
News
Article
Author(s):
Take a look back at our recent coverage relating to our March content theme.
Study Finds Zuranolone Effective for Anhedonia in Patients With PPD
Blue Light Blockers: A Behavior Therapy for Mania
The Double-Edged Sword of Affluence
Treating ‘Morally Objectionable’ Patients
FDA Filing Fee Waiver for New Drug Application of NRX-100 for Suicidal Depression
April in Review: Updates on the Psychiatric Treatment Pipeline